Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats

British Journal of Pharmacology

Volumn 127, Issue 2, 1999, Pages 315-320

  Bandeira Melo, Christianne ^a   Calheiros, Andrea S ^a   Silva, Patricia M R ^a   Cordeiro, Renato S B ^a   Teixeira, Mauro M ^b   Martins, Marco A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Allergic pleurisy; B2 receptor antagonists; Bradykinin; Eosinophils; Neutrophils; Oedema

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; ALLERGEN; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EOSINOPHIL; FEMALE; INFLAMMATION; INTRAPLEURAL DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MALE; MAST CELL; MAST CELL DEGRANULATION; NEUTROPHILIA; NONHUMAN; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; RAT; SENSITIZATION;

ALLERGENS; ANIMALS; ANTI-ALLERGIC AGENTS; BRADYKININ; CELL DEGRANULATION; EXUDATES AND TRANSUDATES; FEMALE; HISTAMINE RELEASE; LEUKOCYTES; MALE; MAST CELLS; P-METHOXY-N-METHYLPHENETHYLAMINE; PLATELET ACTIVATING FACTOR; PLEURISY; PROTEINS; QUINOLINES; RATS; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0033024211     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702536     Document Type: Article

References (43)

1. Abe, K., Watanabe, N., Kumagai, N., Mouri, T., Seki, T., & Yoshinaga, K. (1967). Circulating plasma kinin in patients with bronchial asthma. Experientia., 23, 626-627.
2. Abraham, W.M., Burch, R.M., Farmer, S.G., Ahmed, A. & Cortes, A., (1991). A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am. Rev. Respir. Dis., 143, 787-796.
3. Ahluwalia, A., Giuliani, S., Scotland, R. & Maggi, C.A. (1998). Ovalbumin-induced neurogenic inflammation in the bladder of sensitized rats. Br. J. Pharmacol., 124, 190-196.
4. Akbary, A.M., Wirth, K.J. & Schölkens, B.A. (1996). Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. Immunopharmacol., 33, 238-242.
5. Austin, C.E., Dear, J.W., Neighbour, H., Lung, V. & Foreman, J.C. (1996). The contribution of histamine to action of bradykinin in the human nasal airway. Immunopharmacol., 34, 181-189.
6. Austin, C.E., Foreman, J.C. & Sacdding, G.K. (1994). Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage. Br. J. Pharmacol., 111, 969-971.
7. Bertrand, C., Nadel, J.A., Yamawaki, I. & Geppetti, P. (1993). Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea. J. Immunol., 151, 4902-4907.
8. Bhoolas K., Figueroa, C.D. & Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev., 44, 1-80.
9. Brunnée, T., Nigam, S., Kunkel, G. & Baumgartem, C.R. (1991). Nasal challenge studies with bradykinin: influence upon mediator generation. Clin. Exp. Allergy., 21, 425-431.
10. Christiansen, S.C., Proud, D. & Cochrane, C.G. (1987). Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J. Clin. Invest., 79, 188-197.
11. Devillier, P., Drapeau, G., Renoux, M. & Regoli, D. (1989). Role of the n-terminal arginine in the histamine-releasing activity of substance P. bradykinin and related peptides. Eur. J. Pharmacol., 168, 53-60.
12. Diaz, B.L., Serra, M.F., Alves, A.C., Pires, A.L.A., Correa, F.M.A., Cordeiro, R.S.B., Martins, M.A. & Silva, P.M.R. (1996). Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats. Int. Arch. Allergy. Immunol., 111, 36-43.
13. Farmer, S.C. (1991). Role of kinins in airway diseases. Immunopharmacology, 22, 1-20.
14. Farmer, S.G., Wilkins, D.E., Meeker, S.A., Seeds, E.A.M. & Page, C.P. (1992). Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophil in guinea-pigs. Br. J. Pharmacol., 107, 653-659.
15. Featherstone, R.L., Parry, J.E. & Church, M.K. (1996). The effects of a kinin antagonist on changes in lung function and plasma extravasation into the airways following challenge of sensitized guinea-pigs. Clin. Exp. Allergy., 26, 235-240.
16. Gao, X.P., Akhter, S.R. & Rubinstein, I. (1998). Ovalbumin increases macromolecular efflux from the in situ nasal mucosa of allergic hamsters. J. Appl. Physiol., 84, 169-176.
17. Griesbacher, T. & Legat, F.J. (1997). Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. Br. J. Pharmacol., 120, 933-939.
18. Gornall, A.G., Bardawill, C.J. & David, M.M. (1949). Determination of serum protein by means of the biuret reaction. J. Biol. Chem., 177, 751-766.
19. Hogan, M.B., Harris, K.E., Protter, A. & A., Patterson, R. (1977). A bradykinin antagonist inhibits both bradykinin-and the allergen-induced airway response in primates. Proc. Assoc. Am. Physicians, 109, 269-274.
20. 2 antagonist: in vitro and in vivo studies. Can. J. Physiol. Pharmacol., 75, 622-628.
21. Ishizaka, T., Iwata, M. & Ishizaka, K. (1985). Release of histamine and arachidonate from mouse and mast cells induced by glycosilation-enhancing factor and bradykinin. J. Immunol., 134, 1880-1887.
22. Lembeck, F., Griensbacher, T., Eckhardt, M., Henke, S., Breipohl, G. & Knolle, J. (1991). New long-acting, potent bradykinin antagonists. Br. J. Pharmacol., 102, 297-304.
23. Lima, M.C.R., Chagas, M.S.S., Silva, P.M.R., Calheiros, A.S., Prouvost-Danon, A., Faria-Neto, H.C.C., Cordeiro, R.S.B. & Martins, M.A. (1996). Histamine-potentiating activity in rats anaphylactic pleural fluid: role of serotonin. Braz. J. Med. Biol. Res., 29, 1049-1056.
24. Lima, M.C.R., Martins, M.A., Perez, S.A.C., Silva, P.M.R., Cordeiro, R.S.B. & Vargaftig, B.B. (1991). Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats. Eur. J. Pharmacol., 197, 201-207.
25. Lindström, E.G. & Andersson, R.G.G. (1997). Neurokinin A-LI release after antigen challenge in guinea-pig bronchial tubes: influence of histamine and bradykinin. Br. J. Pharmacol., 122, 417-422.
26. 2 receptor antagonist, FR 173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol., 121, 723-730.
27. Martins, M.A., Pasquale, C.P., Bozza, P.T., Silva, P.M.R., Castro, H.C. & Cordeiro, R.S.B. (1992). Homologous tachyphylaxis to bradykinin and its interference with allergic pleurisy in actively sensitized rats. Eur. J. Pharmacol., 220, 55-61.
28. 2 receptor antagonist FR 173657. Int. Arch. Allergy Immunol., 116, 278-283.
29. Mota, I. (1966). Release of histamine from mast cells. In: Histamine and Antihistaminics, Handbook of Experimental Pharmacology. ed. Rocha e Silva, M. pp 569-636. Berlin: Springer-Verlag.
30. Polosa, R., Lai, C.K.W., Robinson, C. & Holgate, S.T. (1990). The influence of cyclooxygenase inhibition on the loss of bronchoconstrictor response to repeated bradykinin challenge in asthma. Eur. Respir. J., 3, 914-921.
31. Regoli, D. & Barabé, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
32. Regoli, D., Rhaleb, N.-E., Drapeau, G. & Dion, S. (1990). Kinin receptor subtypes. J. Cardiovasc. Pharmacol., 15, S30-S38.
33. Roberts, R.A. (1989). Bradykinin receptors: characterization, distribution and mechanisms of signal transduction. Prog. Growth Factors Res., 1, 237-252.
34. Roberts, R.A. & Gullick, W.J. (1990). Bradykinin receptors undergo ligand induced desensitization. Biochemistry, 29, 1975-1979.
35. Sakamoto, T., Barnes, P.J. & Chung, K.F. (1996). Lack of a role for bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Inflamma. Res., 45, 123-126.
36. Sariaa, A., Martling, C.-R., Yan, Z., Theodorsson-Norheim, E., Gamse, R. & Lundberg, J.M. (1988). Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperuzinium, and vagal nerve stimulation. Am. Rev. Respir. Dis., 137, 1330-1335.
37. Sato, E., Koyama, S., Nomura, H., Kubo, K. & Sekiguchi, M. (1996). Bradykinin stimulates alevolar macrophages to release neutrophil, monocyte and eosinophil chemotactic activity. J. Immunol., 157, 3122-3129.
38. Shore, P.A., Burkhalter, A. & Cohn, V.H. (1959). A method for a fluorimetric assay of histamine in tissues. J. Pharmacol. Exp. Ther., 127, 182-186.
39. Soler, M., Sielczak, M. & Abraham, W.M. (1990). A bradykinin antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm. Pharmacol., 3, 9-15.
40. Stewart, J.M., Gera, L., Chan, D.C., Whalley, E.T., Hanson, W.L. & Zuzack, J.S. (1997). Potent, long-acting bradykinin antagonists for a wide range of applications. Can. J. Physiol. Pharmacol., 75, 719-724.
41. Tiffany, C.W. & Burch, R.M. (1989). Bradykinin stimulates tumour necrosis factor and interleukin-1 release from macrophages. FEBS Lett., 247, 189-192.
42. Vavrek, R. & Stewart, J.M. (1985). Competitive antagonists of bradykinin. Peptides, 6, 161-164.
43. Wirth, K., Hock, F.J., Alibis, U., Liz, W., Alderman, H.G., Anagnostopoulos, H., Henke, S., Breipohl, G., Köning, W., Knolle, J. & Shölkens, B.A. (1991). Hoe 140, a new potent and long acting bradykinin-antagonist: In vivo studies. Br. J. Pharmacol., 102, 774-778.